PartnershipJul 14, 2026, 08:56 AM
Silo Pharma's QwikAgents Joins AMD AI Developer Program
AI Summary
Silo Pharma announced that its subsidiary, QwikAgents, has been accepted into Advanced Micro Devices' (AMD) AI Developer Program. This participation grants QwikAgents access to AMD Developer Cloud credits, advanced AI development tools, and training resources, which are expected to accelerate the development, testing, and deployment of its AI agent platform. QwikAgents aims to make powerful, persistent AI agents accessible to a wide range of users, from individuals to enterprises, with affordable and scalable solutions.
Key Highlights
- Silo Pharma's wholly owned subsidiary, QwikAgents, accepted into AMD AI Developer Program.
- Program provides access to AMD Developer Cloud credits, advanced AI development tools, and training resources.
- Collaboration aims to accelerate development, testing, optimization, training, and deployment of AI agents.
- QwikAgents platform is designed for individuals, developers, small businesses, and enterprises.
- QwikAgents offers starter plans beginning at $14 per month.
- Silo Pharma is a developmental-stage biopharmaceutical company focused on underserved conditions.
Price Impact
More from SILO